AS

Annabel Samimy

#626 out of 660 analysts
Stifel
Automatically Tracked
Tracking: 0 Updated: 24 minutes ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-57.13%
Gain +2.06%
Monthly
-0.23%
Yearly
-2.7%
Drawdown
80.26%
$77,091.72
Equity
Holdings
$77,091.72
Cash
$0
Investment
$114,627.06
-$22,908.28
Profit +$1,553.68
Realized
$14,627.06
Unrealized
-$37,535.35
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
2.06%
Profit
$1,553.68
Win %
0%
This Week
Compared To Last Week
Gain
2.06%
Profit
$1,553.68
Win %
0%
This Month
Compared to last month
Gain
-36.93%
Profit
-$45,134.88
Win %
0%
This Year
Compared to last year
Gain
-25.99%
Profit
-$27,069.38
Win %
63%
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
+2.23%
+$1,196.52
Oculis Holding AG logo
OCS Oculis Holding AG
+1.62%
+$357.16
No Data
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
237
Longs Won
100/237 42%
Profit Factor
0.93
Profitability
Shorts Won
0/0 0%
Standard Deviation
$8,077.34
Average Win
$2,952.73
Best Trade
(Jul 25) $90,120.94
Sharpe Ratio
-37.11
Average Loss
-$2,322.49
Worst Trade
(Oct 04) -$41,359.81
Z-Score
-6.42 (100%)
Commissions
$0
Avg. Trade Length
1m 3w
Expectancy
-$96.66
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 33 30 27 23 20 17 13 10 7 3
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV